ED
SSRI

Exane Derivatives’s Silver Standard Resources SSRI Stock Holding History

Exane Derivatives’s Portfolio SSRI Stock Details SSRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,034
Closed -$117K – 638
2017
Q2 		$117K Buy
12,034
+5,500
+84% +$53.4K 0.03% 230
2017
Q1 		$69.3K Buy
+6,534
New +$69.3K 0.02% 232